Renal Osteodystrophy—Pathogenesis and Treatment
- 1 December 1985
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 290 (6), 234-245
- https://doi.org/10.1097/00000441-198512000-00003
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- The Prevalence of Bone Aluminum Deposition in Renal Osteodystrophy and Its Relation to the Response to Calcitriol TherapyNew England Journal of Medicine, 1982
- Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.Journal of Clinical Investigation, 1980
- TRABECULAR BONE MINERALIZATION LAG TIME DETERMINED BY TETRACYCLINE DOUBLE‐LABELING IN NORMAL AND CERTAIN PATHOLOGICAL CONDITIONSActa Pathologica Microbiologica Scandinavica Section A Pathology, 1980
- Is calcitriol [1,25(OH)2D3] harmful to renal function?Published by American Medical Association (AMA) ,1979
- The predictability of the histological features of uremic bone disease by non-invasive techniquesMetabolic Bone Disease and Related Research, 1978
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978
- Gastrointestinal Absorption of Aluminum from Aluminum-Containing AntacidsNew England Journal of Medicine, 1977
- Hyperparathyroidism and renal failureKidney International, 1973
- On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dogJournal of Clinical Investigation, 1971